NCT06182683 Concurrent OCT and FFR-guided PCI in CAD
| NCT ID | NCT06182683 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Korea University Guro Hospital |
| Condition | Coronary Artery Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 700 participants |
| Start Date | 2023-11-30 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 700 participants in total. It began in 2023-11-30 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study is a prospective randomized clinical trial aimed to compare the therapeutic strategy of angiography-guided versus concurrent OCT/FFR-guided intervention in patients with coronary artery disease.
Eligibility Criteria
Inclusion Criteria: 1. Age greater than 19 years old 2. Patients undergoing coronary stent implantation for stable angina or acute coronary syndrome 3. Patients provided on informed consent Exclusion Criteria: 1. Individuals with a history of increased bleeding tendencies or hematologic disorders 2. Presented with refractory cardiogenic shock 3. Individuals with a history of stent thrombosis 4. Expected life expectancy of less than 1 year 5. Left ventricular ejection fraction (LVEF) ≥ 20% 6. Women who are breastfeeding, pregnant, or planning to become pregnant 7. Deemed unsuitable for participation by the investigator 8. Patients unwilling to participate in the clinical trial
Contact & Investigator
Dong Oh Kang, MD, PhD
PRINCIPAL INVESTIGATOR
Korea University Guro Hospital
Frequently Asked Questions
Who can join the NCT06182683 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06182683 currently recruiting?
Yes, NCT06182683 is actively recruiting participants. Contact the research team at gelly9@naver.com for enrollment information.
Where is the NCT06182683 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06182683 clinical trial?
NCT06182683 is sponsored by Korea University Guro Hospital. The principal investigator is Dong Oh Kang, MD, PhD at Korea University Guro Hospital. The trial plans to enroll 700 participants.